1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. POSEIDA THERAPEUTICS INC

Poseida Therapeutics Inc

XNAS: PSTX

Momentum Trap

Watchlist

Portfolio

Share


Insider Trading disclosures for Poseida Therapeutics Inc

The latest disclosure was made by Cynthia Lynne Collins in Poseida Therapeutics Inc where a trade of 28,500 Stock Option (Right to Buy) done was reported to US exchanges on Jan. 8, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Cynthia Lynne Collins Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 28,500 0 - - Stock Option (Right to Buy)
Cynthia Lynne Collins Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 87,440 0 - - Stock Option (Right to Buy)
Cynthia Lynne Collins Director 08 Jan 2025 58,950 0 - - Common Stock
Cynthia Lynne Collins Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 27,350 0 - - Stock Option (Right to Buy)
Cynthia Lynne Collins Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 27,350 0 - - Stock Option (Right to Buy)
Harry J. Leonhardt GC & Chief Compliance Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 72,568 0 - - Employee Stock Option (Right to Buy)
Harry J. Leonhardt GC & Chief Compliance Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 125,283 0 - - Employee Stock Option (Right to Buy)
Harry J. Leonhardt GC & Chief Compliance Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 137,000 0 - - Employee Stock Option (Right to Buy)
Harry J. Leonhardt GC & Chief Compliance Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 160,385 0 - - Employee Stock Option (Right to Buy)
Harry J. Leonhardt GC & Chief Compliance Officer 08 Jan 2025 223,640 0 - - Common Stock
Harry J. Leonhardt GC & Chief Compliance Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 111,700 0 - - Employee Stock Option (Right to Buy)
Marcea Bland Lloyd Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 16,038 0 - - Stock Option (Right to Buy)
Marcea Bland Lloyd Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 20,000 0 - - Stock Option (Right to Buy)
Marcea Bland Lloyd Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 25,833 0 - - Stock Option (Right to Buy)
Marcea Bland Lloyd Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 28,500 0 - - Stock Option (Right to Buy)
Marcea Bland Lloyd Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 27,350 0 - - Stock Option (Right to Buy)
Marcea Bland Lloyd Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 27,350 0 - - Stock Option (Right to Buy)
Marcea Bland Lloyd Director 08 Jan 2025 68,950 0 - - Common Stock
Marcea Bland Lloyd Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 32,076 0 - - Stock Option (Right to Buy)
Marcea Bland Lloyd Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 20,000 0 - - Stock Option (Right to Buy)
Mark J. Gergen Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 364,060 0 - - Employee Stock Option (Right to Buy)
Mark J. Gergen Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 48,115 0 - - Employee Stock Option (Right to Buy)
Mark J. Gergen Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 75,000 0 - - Employee Stock Option (Right to Buy)
Mark J. Gergen Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 342,000 0 - - Employee Stock Option (Right to Buy)
Mark J. Gergen Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 518,500 0 - - Employee Stock Option (Right to Buy)
Mark J. Gergen Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 172,600 0 - - Employee Stock Option (Right to Buy)
Mark J. Gergen Director, President and CEO 08 Jan 2025 636,726 0 - - Common Stock
Mark J. Gergen Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 240,721 0 - - Employee Stock Option (Right to Buy)
John Schmid Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 25,833 0 - - Stock Option (Right to Buy)
John Schmid Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 27,350 0 - - Stock Option (Right to Buy)
John Schmid Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 27,350 0 - - Stock Option (Right to Buy)
John Schmid Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 28,500 0 - - Stock Option (Right to Buy)
John Schmid Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 32,076 0 - - Stock Option (Right to Buy)
John Schmid Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 16,038 0 - - Stock Option (Right to Buy)
John Schmid Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 20,000 0 - - Stock Option (Right to Buy)
John Schmid Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 20,000 0 - - Stock Option (Right to Buy)
John Schmid Director 08 Jan 2025 58,950 0 - - Common Stock
Charles M. Baum Director 08 Jan 2025 78,600 0 - - Common Stock
Charles M. Baum Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 57,000 0 - - Stock Option (Right to Buy)
Charles M. Baum Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 27,350 0 - - Stock Option (Right to Buy)
Charles M. Baum Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 27,350 0 - - Stock Option (Right to Buy)
Rafael G. Amado Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 55,200 0 - - Stock Option (Right to Buy)
Rafael G. Amado Director 08 Jan 2025 58,950 0 - - Common Stock
Rafael G. Amado Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 27,350 0 - - Stock Option (Right to Buy)
Kristin Yarema President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 345,200 0 - - Employee Stock Option (Right to Buy)
Kristin Yarema President and CEO 08 Jan 2025 615,836 0 - - Common Stock
Kristin Yarema President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 498,325 0 - - Employee Stock Option (Right to Buy)
Johanna M. Mylet Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 80,192 0 - - Employee Stock Option (Right to Buy)
Johanna M. Mylet Chief Financial Officer 08 Jan 2025 254,852 0 - - Common Stock
Johanna M. Mylet Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 4,117 0 - - Employee Stock Option (Right to Buy)
Johanna M. Mylet Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 35,000 0 - - Employee Stock Option (Right to Buy)
Johanna M. Mylet Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 82,000 0 - - Employee Stock Option (Right to Buy)
Johanna M. Mylet Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 65,000 0 - - Employee Stock Option (Right to Buy)
Johanna M. Mylet Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 72,568 0 - - Employee Stock Option (Right to Buy)
Johanna M. Mylet Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 125,283 0 - - Employee Stock Option (Right to Buy)
Johanna M. Mylet Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 111,700 0 - - Employee Stock Option (Right to Buy)
Luke Corning Director 08 Jan 2025 58,950 0 - - Common Stock
Luke Corning Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 27,350 0 - - Stock Option (Right to Buy)
Luke Corning Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 28,500 0 - - Stock Option (Right to Buy)
Luke Corning Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 45,833 0 - - Stock Option (Right to Buy)
Luke Corning Director Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 27,350 0 - - Stock Option (Right to Buy)
Syed Ali-aamir Rizvi Chief Medical Officer 08 Jan 2025 185,000 0 - - Common Stock
Syed Ali-aamir Rizvi Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 08 Jan 2025 250,000 0 - - Employee Stock Option (Right to Buy)
Mark J. Gergen Director, Executive Chairman Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.60 per share. 02 Jan 2025 23,313 630,726 - 9.6 223,805 Common Stock
Mark J. Gergen Director, Executive Chairman Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2024 30,000 96,372 - - Employee Stock Option (Right to Buy)
Mark J. Gergen Director, Executive Chairman Sale of securities on an exchange or to another person at price $ 9.46 per share. 10 Dec 2024 30,000 651,291 - 9.5 283,866 Common Stock
Mark J. Gergen Director, Executive Chairman Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.78 per share. 10 Dec 2024 30,000 681,291 - 2.8 83,430 Common Stock
Mark Gergen J. Director, Executive Chairman Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Nov 2024 30,000 126,372 - - Employee Stock Option (Right to Buy)
J. Mark Gergen Director, Executive Chairman Sale of securities on an exchange or to another person at price $ 9.27 per share. 26 Nov 2024 30,000 651,291 - 9.3 278,100 Common Stock
J. Gergen Mark Director, Executive Chairman Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.78 per share. 26 Nov 2024 30,000 681,291 - 2.8 83,430 Common Stock
Cynthia Collins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 19,650 58,950 - 0 Common Stock
Cynthia Collins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 27,350 27,350 - - Stock Option (Right to buy)
Marcea Bland Lloyd Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 19,650 68,950 - 0 Common Stock
Marcea Bland Lloyd Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 27,350 27,350 - - Stock Option (Right to buy)
John Schmid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 27,350 27,350 - - Stock Option (Right to buy)
John Schmid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 19,650 58,950 - 0 Common Stock
Charles M. Baum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 19,650 78,600 - 0 Common Stock
Charles M. Baum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 27,350 27,350 - - Stock Option (Right to buy)
Rafael G. Amado Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 19,650 58,950 - 0 Common Stock
Rafael G. Amado Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 27,350 27,350 - - Stock Option (Right to buy)
Luke Corning Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 19,650 58,950 - 0 Common Stock
Luke Corning Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 27,350 27,350 - - Stock Option (Right to buy)
Syed Ali-aamir Rizvi Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2024 185,000 185,000 - 0 Common Stock
Syed Ali-aamir Rizvi Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2024 250,000 250,000 - - Employee Stock Option (Right to Buy)
Harry J. Leonhardt GC & Chief Compliance Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 80,743 230,946 - 0 Common Stock
Harry J. Leonhardt GC & Chief Compliance Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 111,700 111,700 - - Employee Stock Option (Right to Buy)
Harry J. Leonhardt GC & Chief Compliance Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.13 per share. 01 Mar 2024 16,306 214,640 - 4.1 67,344 Common Stock
Mark J. Gergen Director, Executive Chairman Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.13 per share. 01 Mar 2024 34,157 651,291 - 4.1 141,068 Common Stock
Johanna M. Mylet Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 111,700 111,700 - - Employee Stock Option (Right to Buy)
Johanna M. Mylet Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 80,743 264,374 - 0 Common Stock
Johanna M. Mylet Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.13 per share. 01 Mar 2024 18,091 246,283 - 4.1 74,716 Common Stock
Brent Warner President, Gene Therapy Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 111,700 111,700 - - Employee Stock Option (Right to Buy)
Brent Warner President, Gene Therapy Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 80,743 454,779 - 0 Common Stock
Brent Warner President, Gene Therapy Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.13 per share. 01 Mar 2024 35,739 419,040 - 4.1 147,602 Common Stock
J. Gergen Mark Director, Executive Chairman Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.41 per share. 01 Feb 2024 47,162 685,448 - 3.4 160,822 Common Stock
Kristin Yarema Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 345,200 345,200 - - Stock Option (Right to buy)
Kristin Yarema Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 250,000 606,836 - 0 Common Stock
Mark J. Gergen Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 125,000 732,610 - 0 Common Stock
Gergen Mark J. Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 172,600 172,600 - - Stock Option (Right to buy)
Cynthia Collins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 27,350 27,350 - - Stock Option (Right to buy)
Cynthia Collins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 19,650 39,300 - 0 Common Stock
Marcea Bland Lloyd Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 27,350 27,350 - - Stock Option (Right to buy)
Marcea Bland Lloyd Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 19,650 49,300 - 0 Common Stock
John Schmid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 27,350 27,350 - - Stock Option (Right to buy)
John Schmid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 19,650 39,300 - 0 Common Stock
Charles M. Baum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 27,350 27,350 - - Stock Option (Right to buy)
Charles M. Baum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 19,650 58,950 - 0 Common Stock
Luke Corning Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 27,350 27,350 - - Stock Option (Right to buy)
Luke Corning Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 19,650 39,300 - 0 Common Stock
Rafael G. Amado Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2023 55,200 55,200 - - Stock Option (Right to Buy)
Rafael G. Amado Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2023 39,300 39,300 - 0 Common Stock
Kristin Yarema President, Cell Therapy Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Apr 2023 498,325 498,325 - - Employee Stock Option (Right to Buy)
Kristin Yarema President, Cell Therapy Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Apr 2023 356,836 356,836 - 0 Common Stock
Harry J. Leonhardt GC & Chief Compliance Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.35 per share. 01 Mar 2023 4,323 144,203 - 5.3 23,128 Common Stock
Harry J. Leonhardt GC & Chief Compliance Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 92,772 148,526 - 0 Common Stock
Harry J. Leonhardt GC & Chief Compliance Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 125,283 125,283 - - Employee Stock Option (Right to Buy)
Mark J. Gergen Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 364,060 364,060 - - Employee Stock Option (Right to Buy)
Mark J. Gergen Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 269,586 601,610 - 0 Common Stock
Johanna M. Mylet Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 125,283 125,283 - - Employee Stock Option (Right to Buy)
Johanna M. Mylet Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.35 per share. 01 Mar 2023 4,323 177,631 - 5.3 23,128 Common Stock
Johanna M. Mylet Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 92,772 181,954 - 0 Common Stock
Brent Warner President, Gene Therapy Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 92,772 400,653 - 0 Common Stock
Brent Warner President, Gene Therapy Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 125,283 125,283 - - Stock Option (Right to Buy)
Brent Warner President, Gene Therapy Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.35 per share. 01 Mar 2023 26,617 374,036 - 5.4 142,401 Common Stock
Mark J. Gergen Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.00 per share. 01 Feb 2023 31,819 330,314 - 7 222,733 Common Stock
Eric Ostertag Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.00 per share. 01 Feb 2023 11,776 827,320 - 7 82,432 Common Stock
Eric Ostertag Director, Executive Chairman, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.50 per share. 08 Aug 2022 142,857 838,824 - 3.5 500,000 Common Stock
Eric Ostertag Director, Executive Chairman, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 3.69 per share. 03 Aug 2022 160,696 0 - 3.7 592,808 Common Stock
Cynthia Collins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 28,500 28,500 - - Stock Option (Right to Buy)
Cynthia Collins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 19,650 19,650 - 0 Common Stock
Marcea Bland Lloyd Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 28,500 28,500 - - Stock Option (Right to Buy)
Marcea Bland Lloyd Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 19,650 29,650 - 0 Common Stock
John Schmid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 19,650 19,650 - 0 Common Stock
John Schmid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 28,500 28,500 - - Stock Option (Right to Buy)
Charles M. Baum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 57,000 57,000 - - Stock Option (Right to Buy)
Charles M. Baum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 39,300 39,300 - 0 Common Stock
Luke Corning Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 19,650 19,650 - 0 Common Stock
Luke Corning Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 28,500 28,500 - - Stock Option (Right to Buy)
Harry J. Leonhardt GC & Chief Compliance Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 50,000 50,000 - 0 Common Stock
Harry J. Leonhardt GC & Chief Compliance Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 72,568 72,568 - - Employee Stock Option (Right to Buy)
Kerry D. Ingalls Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 50,000 52,000 - 0 Common Stock
Kerry D. Ingalls Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 72,568 72,568 - - Employee Stock Option (Right to Buy)
Matthew A. Spear Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 50,000 111,485 - 0 Common Stock
Matthew A. Spear Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 72,568 72,568 - - Employee Stock Option (Right to Buy)
Johanna M. Mylet Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 72,568 72,568 - - Employee Stock Option (Right to Buy)
Johanna M. Mylet Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 50,000 84,231 - 0 Common Stock
Brent Warner President, Gene Therapy Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 431,034 431,034 - - Stock Option (Right to Buy)
Brent Warner President, Gene Therapy Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 307,881 307,881 - 0 Common Stock
Mark J. Gergen Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 518,500 518,500 - - Stock Option (Right to Buy)
Mark J. Gergen Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 357,200 357,200 - 0 Common Stock
Eric Ostertag Director, Executive Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 89,500 692,967 - 0 Common Stock
Eric Ostertag Director, Executive Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 118,708 118,708 - - Employee Stock Option (Right to Buy)
Eric Ostertag Director, Executive Chairman, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 01 Feb 2022 48,902 580,292 - 0 Common Stock
Eric Ostertag Director, Executive Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 10,792 10,792 - - Employee Stock Option (Right to Buy)
Eric Ostertag Director, Executive Chairman, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 01 Feb 2022 93,955 603,467 - 0 Common Stock
Johanna M. Mylet Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2021 3,100 3,816 - - Stock Option (Right to Buy)
Johanna M. Mylet Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.93 per share. 21 Dec 2021 3,100 34,231 - 1.9 5,992 Common Stock
Johanna M. Mylet Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2021 2,616 0 - - Stock Option (Right to Buy)
Johanna M. Mylet Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.17 per share. 21 Dec 2021 2,616 31,131 - 1.2 3,069 Common Stock
Matthew A. Spear Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.32 per share. 06 Dec 2021 10,000 61,485 - 1.3 13,220 Common Stock
Matthew A. Spear Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Dec 2021 10,000 70,861 - - Stock Option (Right to Buy)
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.15 per share. 19 Nov 2021 1,000 697,422 - 9.2 9,150 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Nov 2021 1,000 739,995 - - Employee Stock Option (Right to Buy)
Kerry D. Ingalls Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 7.00 per share. 17 Nov 2021 2,000 2,000 - 7 14,000 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 7.09 per share. 08 Nov 2021 9,051 3,358,455 - 7.1 64,172 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 7.09 per share. 08 Nov 2021 9,873 3,659,503 - 7.1 70,000 Common Stock
Johanna M. Mylet Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2021 65,000 65,000 - - Employee Stock Option (Right to Buy)
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.15 per share. 11 Oct 2021 18,525 696,422 - 9.2 169,504 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Oct 2021 18,525 740,995 - - Employee Stock Option (Right to Buy)
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 7.02 per share. 01 Oct 2021 9,579 3,367,506 - 7.0 67,245 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 7.02 per share. 01 Oct 2021 10,450 3,669,376 - 7.0 73,359 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 8.00 per share. 20 Sep 2021 20,000 160,696 - 8.0 160,020 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Sep 2021 18,524 759,520 - - Employee Stock Option (Right to Buy)
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Sep 2021 2,757 0 - - Employee Stock Option (Right to Buy)
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 8.14 per share. 13 Sep 2021 20,000 180,696 - 8.1 162,712 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.15 per share. 13 Sep 2021 18,524 675,415 - 9.2 169,495 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.17 per share. 13 Sep 2021 2,757 656,891 - 1.2 3,234 Common Stock
Matthew A. Spear Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.32 per share. 09 Sep 2021 10,000 51,485 - 1.3 13,220 Common Stock
Matthew A. Spear Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Sep 2021 10,000 80,861 - - Stock Option (Right to Buy)
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 8.34 per share. 01 Sep 2021 29,299 3,377,085 - 8.3 244,354 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 8.46 per share. 01 Sep 2021 24,463 3,406,384 - 8.5 206,957 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 8.34 per share. 01 Sep 2021 31,963 3,679,826 - 8.3 266,571 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 8.46 per share. 01 Sep 2021 26,686 3,711,789 - 8.5 225,764 Common Stock
Luke Corning Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Aug 2021 45,833 45,833 - - Stock Option (Right to Buy)
Matthew A. Spear Chief Medical Officer Sale of securities on an exchange or to another person at price $ 8.79 per share. 20 Aug 2021 4,000 41,485 - 8.8 35,142 Common Stock
Matthew A. Spear Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Aug 2021 4,000 90,861 - - Stock Option (Right to Buy)
Matthew A. Spear Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.32 per share. 20 Aug 2021 4,000 45,485 - 1.3 5,288 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2021 111,149 778,044 - - Employee Stock Option (Right to Buy)
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.15 per share. 06 Aug 2021 111,149 654,134 - 9.1 1,017,013 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 8.13 per share. 02 Aug 2021 7,167 3,748,876 - 8.1 58,268 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 7.99 per share. 02 Aug 2021 9,535 3,430,847 - 8.0 76,185 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 8.13 per share. 02 Aug 2021 6,570 3,440,382 - 8.1 53,414 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 7.99 per share. 02 Aug 2021 10,401 3,738,475 - 8.0 83,104 Common Stock
Matthew A. Spear Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.32 per share. 28 Jul 2021 20,000 41,485 - 1.3 26,440 Common Stock
Matthew A. Spear Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jul 2021 20,000 94,861 - - Stock Option (Right to Buy)
Cynthia Collins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2021 87,440 87,440 - - Stock Option (Right to Buy)
Marcea Bland Lloyd Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2021 25,833 25,833 - - Stock Option (Right to Buy)
John Schmid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2021 25,833 25,833 - - Stock Option (Right to Buy)
David Hirsch Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2021 25,833 25,833 - - Stock Option (Right to Buy)
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 9.77 per share. 01 Jul 2021 10,729 3,770,413 - 9.8 104,822 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 9.65 per share. 01 Jul 2021 104 3,770,309 - 9.7 1,004 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 8.90 per share. 01 Jul 2021 14,266 3,756,043 - 8.9 126,967 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 9.77 per share. 01 Jul 2021 9,834 3,460,124 - 9.8 96,078 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 9.65 per share. 01 Jul 2021 96 3,460,028 - 9.6 926 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 8.90 per share. 01 Jul 2021 13,076 3,446,952 - 8.9 116,376 Common Stock
Matthew A. Spear Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Jun 2021 5,000 114,861 - - Stock Option (Right to Buy)
Matthew A. Spear Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.32 per share. 17 Jun 2021 5,000 21,485 - 1.3 6,610 Common Stock
Marcea Bland Lloyd Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 20,000 20,000 - - Stock Option (Right to Buy)
John Schmid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 20,000 20,000 - - Stock Option (Right to Buy)
David Hirsch Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 20,000 20,000 - - Stock Option (Right to Buy)
Matthew A. Spear Chief Medical Officer Sale of securities on an exchange or to another person at price $ 9.44 per share. 11 Jun 2021 4,000 16,485 - 9.4 37,747 Common Stock
Matthew A. Spear Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jun 2021 4,000 119,861 - - Stock Option (Right to Buy)
Matthew A. Spear Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.32 per share. 11 Jun 2021 4,000 20,485 - 1.3 5,288 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 8.34 per share. 01 Jun 2021 21,246 3,781,142 - 8.3 177,192 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 8.34 per share. 01 Jun 2021 19,476 3,469,958 - 8.3 162,430 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 8.61 per share. 01 Jun 2021 19,701 3,489,434 - 8.6 169,626 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 8.61 per share. 01 Jun 2021 21,493 3,802,388 - 8.6 185,055 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 8.44 per share. 03 May 2021 18,775 3,823,881 - 8.4 158,461 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 8.44 per share. 03 May 2021 17,211 3,509,135 - 8.4 145,261 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 9.01 per share. 03 May 2021 8,765 3,526,346 - 9.0 78,973 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 9.01 per share. 03 May 2021 9,561 3,842,656 - 9.0 86,145 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 9.62 per share. 01 Apr 2021 28,549 3,853,834 - 9.6 274,784 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 10.32 per share. 01 Apr 2021 1,483 3,532,624 - 10.3 15,307 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 9.62 per share. 01 Apr 2021 26,170 3,534,107 - 9.6 251,886 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 9.55 per share. 01 Apr 2021 27,347 3,560,277 - 9.6 261,284 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 10.32 per share. 01 Apr 2021 1,617 3,852,217 - 10.3 16,691 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 9.55 per share. 01 Apr 2021 29,834 3,882,383 - 9.6 285,046 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 11.66 per share. 01 Mar 2021 27,226 3,617,885 - 11.7 317,455 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 11.54 per share. 01 Mar 2021 27,290 3,590,111 - 11.5 314,899 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 12.12 per share. 01 Mar 2021 484 3,617,401 - 12.1 5,866 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 11.54 per share. 01 Mar 2021 29,770 3,912,217 - 11.5 343,516 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 12.12 per share. 01 Mar 2021 528 3,941,987 - 12.1 6,399 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 11.66 per share. 01 Mar 2021 29,702 3,942,515 - 11.7 346,325 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.17 per share. 23 Feb 2021 111,395 542,985 - 1.2 130,666 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2021 111,395 2,757 - - Employee Stock Option (Right to Buy)
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 10.00 per share. 16 Feb 2021 133,149 200,696 - 10.0 1,332,036 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.29 per share. 10 Feb 2021 67,534 431,590 - 1.3 87,119 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2021 67,534 0 - - Employee Stock Option (Right to Buy)
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 10.00 per share. 10 Feb 2021 12,389 333,845 - 10 123,890 Common Stock
Harry J. Leonhardt GC & Chief Compliance Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 137,000 137,000 - - Employee Stock Option (Right to Buy)
Mark J. Gergen Director, President and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 342,000 342,000 - - Employee Stock Option (Right to Buy)
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 889,193 889,193 - - Employee Stock Option (Right to Buy)
Kerry D. Ingalls Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 137,000 137,000 - - Employee Stock Option (Right to Buy)
Matthew A. Spear Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 164,000 164,000 - - Employee Stock Option (Right to Buy)
Johanna M. Mylet Senior Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 82,000 82,000 - - Employee Stock Option (Right to Buy)
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 10.00 per share. 21 Jan 2021 4,462 346,234 - 10 44,620 Common Stock
Matthew A. Spear Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.32 per share. 15 Jan 2021 7,564 11,485 - 1.3 10,000 Common Stock
Matthew A. Spear Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2021 7,564 132,861 - - Stock Option (Right to Buy)
Johanna M. Mylet Senior Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2021 4,177 0 - - Stock Option (Right to Buy)
Johanna M. Mylet Senior Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. 15 Jan 2021 4,728 26,813 - 0.3 1,418 Common Stock
Johanna M. Mylet Senior Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2021 551 0 - - Stock Option (Right to Buy)
Matthew A. Spear Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.32 per share. 08 Jan 2021 3,921 3,921 - 1.3 5,184 Common Stock
Matthew A. Spear Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jan 2021 3,921 140,425 - - Stock Option (Right to Buy)
Marcea Bland Lloyd Director Purchase of securities on an exchange or from another person at price $ 16.00 per share. 14 Jul 2020 10,000 10,000 - 16 160,000 Common Stock
Sean E. Murphy Director, Ten Percent Owner 14 Jul 2020 860,585 0 - - Series B Preferred Stock
Sean E. Murphy Director, Ten Percent Owner 14 Jul 2020 1,457,725 0 - - Series A-1 Preferred Stock
Sean E. Murphy Director, Ten Percent Owner 14 Jul 2020 8,746,356 0 - - Series A Preferred Stock
Sean E. Murphy Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 16.00 per share. 14 Jul 2020 10,000 10,000 - 16 160,000 Common Stock
Sean E. Murphy Director, Ten Percent Owner 14 Jul 2020 315,098 9,188,125 - - Common Stock
Sean E. Murphy Director, Ten Percent Owner 14 Jul 2020 690,124 8,873,027 - - Common Stock
Sean E. Murphy Director, Ten Percent Owner 14 Jul 2020 7,013,918 7,013,918 - - Common Stock
Sean E. Murphy Director, Ten Percent Owner 14 Jul 2020 1,168,985 8,182,903 - - Common Stock
Sean E. Murphy Director, Ten Percent Owner 14 Jul 2020 392,927 0 - - Series C Preferred Stock
David Hirsch Director 14 Jul 2020 2,581,755 0 - - Series B Preferred Stock
David Hirsch Director 14 Jul 2020 2,464,245 2,464,245 - - Common Stock
David Hirsch Director 14 Jul 2020 491,159 0 - - Series C Preferred Stock
David Hirsch Director Purchase of securities on an exchange or from another person at price $ 16.00 per share. 14 Jul 2020 250,000 2,714,245 - 16 4,000,000 Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner 14 Jul 2020 350,696 350,696 - - Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner 14 Jul 2020 255,845 629,194 - - Common Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner 14 Jul 2020 437,318 0 - - Series A-1 Preferred Stock
Eric Ostertag Director, Chief Executive Officer, Ten Percent Owner 14 Jul 2020 319,039 0 - - Series A Preferred Stock
Marcea Bland Lloyd Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jul 2020 20,000 20,000 - - Stock Option (Right to Buy)
Mark J. Gergen Director, President and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jul 2020 75,000 75,000 - - Stock Option (Right to Buy)
Sean E. Murphy Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jul 2020 20,000 20,000 - - Stock Option (Right to Buy)
John Schmid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jul 2020 20,000 20,000 - - Stock Option (Right to Buy)
Catherine J. Mackey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jul 2020 20,000 20,000 - - Stock Option (Right to Buy)
David Hirsch Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jul 2020 20,000 20,000 - - Stock Option (Right to Buy)
Johanna M. Mylet Senior Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jul 2020 35,000 35,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters